Business Wire

ADVA

Share
ADVA expands Ensemble Harmony Ecosystem to include disaggregated packet networking

ADVA (FSE: ADV) today announced the expansion of its Ensemble Harmony Ecosystem to include disaggregated packet networking. Alpha Networks, Delta, Edgecore Networks and UfiSpace have all joined the open multi-vendor program. Each new member offers high-performance hardware platforms proven to interoperate with ADVA’s Ensemble Activator, a carrier-grade network operating system (NOS) specifically designed for white box switches. The Ensemble Harmony Ecosystem helps to accelerate softwarization and virtualization by offering service providers and enterprises access to the industry’s most comprehensive portfolio of flexible and disaggregated networking technologies. The addition of white box switch suppliers means it now delivers even more value to customers and helps to further simplify their transition to software-driven networking.

“Since the inception of NFV, our Ensemble Harmony Ecosystem has led the way, delivering unparalleled variety and choice of onboarded virtual network functions (VNFs). Now we’re opening up this unique multi-vendor environment to include some of the industry’s most innovative hardware suppliers, ensuring easy interoperability and new levels of collaboration for the rapid development of future services,” said James Buchanan, GM, Edge Cloud, ADVA. “This latest expansion of Ensemble Harmony will help more customers to realize the true value of virtualization and disaggregated packet networking as a catalyst to openness, componentized systems and innovation at the speed of software. The journey to white box switches and servers and software-driven networking is now simpler and more cost-efficient than ever before. ADVA is now the clear leader in network operating systems for white boxes.”

With the addition of leading hardware suppliers, ADVA’s open Ensemble Harmony Ecosystem provides everything service providers and businesses require to harness the power of disaggregated networking. Each of the new member companies offers highly efficient white box technology proven to interoperate successfully with ADVA’s Ensemble Activator , the first NOS designed for bare-metal switches. Already successful in trials with multiple global mobile network operators, including Telefónica and Vodafone, Ensemble Activator is the market’s most versatile operating system for disaggregated cell site gateways. When combined with Ensemble Harmony partner hardware, it offers new levels of agility and freedom and a clear route to cost-effective mass rollout of 5G services over large, geographically dispersed, multi-vendor networks.

“We’re excited to be among the first hardware partners to be welcomed into the Ensemble Harmony Ecosystem. It’s a community that shares our dedication to openness and interoperability. Together we can remove even more of the shackles of single-vendor proprietary solutions,” commented George Tchaparian, CEO, Edgecore Networks. “Today’s customers refuse to accept the constraints, the complexity and the expense of closed hardware and software systems. They demand the freedom to build scalable, cost-effective infrastructure on best-in-class open products and solutions. That’s why we’re working closely with Ensemble Harmony software partners, helping operators make the leap to virtualization and harness the benefits of openness and disaggregation.”

“ADVA’s Ensemble Harmony Ecosystem is a pillar of the open environment. Its philosophy is perfectly aligned with our own focus on disaggregation and open networking. What’s more, by collaborating with ADVA, we can add more value to our innovations and increase speed to market for our customers,” said Vincent Ho, CEO, UfiSpace. “We’ve been driving the next generation of open networking solutions with our carrier-grade disaggregated white box and network cloud solutions. Now, as part of Ensemble Harmony, we can give even more customers the freedom to choose from a wide range of fully integrated software and hardware technologies and select the ideal disaggregated solution for their business needs.”


About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

Social Media:

https://www.facebook.com/ADVAOpticalNetworking

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release

Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye